| A awm theih dan: | |
|---|---|
Product Hming |
Dermal Filler a ni |
Lampang |
50mL/vial ah a awm |
Thil siamna atana hmanraw pawimawh ber ber |
25 mg/ml Sodium Hyaluronate hmanga inzawmkhawm (cross-linked Sodium Hyaluronate) a ni 3 mg/ml Lidocaine Hydrochloride ei tur a ni |
Injection thuk zawng |
Dermis thuk tak emaw, vun hnuaia awm emaw |
Injection Hmun hrang hrang |
Chest(breast) leh buttocks(gluteal region)–soft tissue volume tihpun nan |
| Particle Size a ni | Injection hmasa ber Dose: 1.1. Top-up Injection pek dan tur chu: |
Rei zawng |
Thla 12-24 chhung a ni |
| Shelf Life a ni | Kum 3 chhung |
Bodyfill Vial 50ml hi CE & FDA dual-certified a ni a, 6 Sigma standards zawm thei GMP workshop level 100-a siam a ni. ISO 13485 hian lifecycle quality control kimchang a tichiang a, defect rate 0.03% hnuai lam a nei bawk. SGS chuan professional test 46 hmangin independent takin a verified a, chung zingah chuan infrared analysis & in-vivo degradation simulations te pawh a tel. MSDS safety data authentication hian hman dan tur kaihhruaina kimchang tak a pe a ni.


AOMA Bodyfill Vial 50ml Dermal Filler hi taksa lem siamna atana siam bik a ni. A core function chu zawi zawia lift leh contour a ni a, line fullness leh smoothness tihchangtlun lutuk lovin, rounded leh firm shape a siam a, effects thla 12-18 chhung a awm thei. Clinical observation-ah chuan soft feel leh a chhehvel tissue te nen 98% integration rate a awm tih hmuhchhuah a ni a, stiffness report a awm lo.

Body filler hi eng nge ni a, facial filler nen engtin nge a danglam?
Body fillers hi HA gels a ni a, buttocks leh breasts te chu large-volume contouring atan a hmang a, facial fillers aiin cross-linking density sang zawk a nei a, tissue pressure thuk zawk tuar thei tur leh volume nghet tak pe thei tur a ni.
Body filler hi eng chen nge a daih?
AOMA Bodyfill Vial 50ml hi thla 12 atanga thla 24 chhung a daih thei. Dam rei theihna chu cross-linking technology, injection depth, leh mimal metabolism-ah a innghat a ni.
Injection pek dan hian a ti na em?
Filler-ah lidocaine pre-mixed tawh leh topical anesthetic hman hmasak a nih chuan, damlote chuan minute 30–60 chhunga an tih chhung hian pressure emaw mild pinching emaw chauh an nei a, hei hian general anesthesia a mamawh lo.
A result ka duh loh chuan body filler hi a dissolve thei ang em?
Awle. Body fillers hi hyaluronidase hmangin reversible a ni a, hei hian HA hi him takin a tichhia a ni. Hei hian body filler hi surgical implant emaw permanent filler emaw aiin low-commitment choice a siam a ni.
Quality body filler ah hian eng certification nge ka zawn tur?
CE & FDA certification, ISO 13485 quality management, SGS third-party testing, leh MSDS safety documentation te zawng rawh. Hengte hian khawvel pum huapa himna leh hman tangkai dan tur tehfung a tlin theih nan a pui a ni.
| Product Hming | Dermal Filler |
|---|---|
| chi hrang hrang | 50mL/vial |
| A hmanraw pawimawh ber ber | 25 mg/ml Cross-linked Sodium Hyaluronate 3 mg/ml Lidocaine Hydrochloride |
| Injection thuk zawng | Dermis thuk tak emaw, vun hnuaia awm emaw |
| Injection Areas | Chest(breast) leh buttocks(gluteal region)–soft tissue volume tihpun nan |
| Particle Size | Injection hmasa ber Dose: Unilateral breast: ≤50mL; Unilateral hnute: ≤100mL Top-up Injection Dose: Hnute pakhat: ≤20mL; Unilateral buttock: ≤30mL |
| A hun chhung | Thla 12-24 chhung |
| Packing | 1 PCS/BOX A nih loh leh Customized a ni |
| Order tlem ber a ni | MOQ hi unit 200 atanga tan a ni. |
|---|---|
| Standard Packing a ni | 1 PCS/BOX A nih loh leh |
| OEM / Private Label hmanga siam a ni | OEM / private label order atan logo, formula, capacity leh packaging customization a awm thei. |
| Certification pek chhuah a ni | AOMA hian CE, ISO 13485, GMP leh FDA certificate a nei a ni. Documentation pawh dil theih a ni. |
| Order dan tur | kha click la INQUIRY NOW tih , WhatsApp emaw email emaw hmangin min rawn biak theih chuan product, quantity leh destination ram ziakin min rawn biak theih reng e. |
| Stock Order te pawh a awm bawk | Stock order te chu darkar 24 chhungin an thawn chhuak thin. |
|---|---|
| OEM / Custom Order te a awm bawk | Artwork, formula, leh packaging details zawng zawng confirm a nih atanga kar 2–3 hnuah. |
| Thawnchhuak | International express: DHL / FedEx / UPS te a ni a, a hmunah hian mipui an pungkhawm nasa hle. |
![]() Logo Design siam a ni |
Ampoules ah Logo Design siam a ni |
Product Box ah Logo Design siam a ni |
Dermal Filler Packaging chungchangah Logo Design siam a ni |
Vial-a Logo Design siam a ni |
Dermal Filler Label ah Logo Design siam a ni |
![]() +III Collagen a ni |
![]() +Lidocaine tih hi a ni |
+PDRN a ni |
+PLLA |
+Semaglutide a ni |
+Semaglutide a ni |
![]() Ampoules te pawh a awm |
Ampoules te pawh a awm |
BD 1ml 2ml 10ml 20ml Syringe hmanga siam a ni |
Vials te pawh a awm |
Packaging siam dan tur ruahmanna siam a ni |
![]() Packaging siam dan tur ruahmanna siam a ni |
Packaging siam dan tur ruahmanna siam a ni |
Packaging siam dan tur ruahmanna siam a ni |
Packaging siam dan tur ruahmanna siam a ni |
Packaging siam dan tur ruahmanna siam a ni |
Saxenda (liraglutide, nitin) atanga Wegovy (semaglutide, kar tin) lama inthlak hi damlote tan chuan taksa rihna tihtlem tam zawk emaw, injection tlem zawk emaw duh tan chuan a awm fo thin. Official US labels leh published guidance atanga chhut chuan, he guide hian damlote inthlak chhan a sawifiah a, dosing schedule te a khaikhin a, transition step by step a tarlang bawk: washout a ngai lo, Wegovy hian Saxenda dose hnuhnung ber hnu ni khatah a tan thei tlangpui a, starting dose chu a tlangpuiin 0.25 mg a ni (0.5 mg chu off-label anga ngaih damlo thenkhat tan 3 mg-a stable) a ni a, escalation hi 4 mg danah a thleng thin kar khat chhung a ni. GI side effect beisei, STEP 8 trial result, tihsual tlanglawn leh GLP-1 trend hian aesthetic clinic leh distributor te tana a awmzia te pawh a huam tel bawk.
A dang pawh en rawhTranexamic acid (TXA) mesotherapy hi melasma rilru na tak enkawlna clinic-te tan chuan go-to option a ni ta a ni. He guide hian TXA hian pigment siamna tichaktu plasmin signal a tihbuai dan te, clinical study chhuah tawhte’n a lantir dan te (Lee 2006; Budamakuntla 2013), typical intradermal TXA protocol kalpui dan te, eng brightening actives nge a pair tha em em te, key safety considerations te, leh TXA formula import emaw private-label tum distributor leh clinic brand te tan sourcing checklist te a sawifiah a ni.
A dang pawh en rawhAOMA nen inhmu rawh
Laboratory-ah a awm a
Product Category hrang hrang a awm
Blog hrang hrangah a awm